Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
202.48B
Market cap202.48B
Price-Earnings ratio
11.13
Price-Earnings ratio11.13
Dividend yield
2.70%
Dividend yield2.70%
Average volume
12.24M
Average volume12.24M
High today
$46.42
High today$46.42
Low today
$45.42
Low today$45.42
Open price
$46.17
Open price$46.17
Volume
8.50M
Volume8.50M
52 Week high
$64.16
52 Week high$64.16
52 Week low
$35.12
52 Week low$35.12

NVO News

The Motley Fool 58m
Should Eli Lilly Investors Be Worried About a Threat From Amylyx?

Eli Lilly (LLY -0.13%) was the second company to market a GLP-1 drug. That's important to keep in mind as you look at the competitive landscape for this new cla...

Should Eli Lilly Investors Be Worried About a Threat From Amylyx?
Nasdaq 18h
Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?

Key Points Novo Nordisk was first with a GLP-1 weight-loss shot, but lost the lead to Eli Lilly. Novo Nordisk was first to market with a GLP-1 pill, though El...

Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?
Financial Times 3d
Big Pharma steps up fight against counterfeit weight-loss drugs - Financial Times

...

Big Pharma steps up fight against counterfeit weight-loss drugs - Financial Times

More NVO News

Simply Wall St 3d
Novo Nordisk Could Be 54% Undervalued Following Deutsche Bank Downgrade

Deutsche Bank’s downgrade of Novo Nordisk (NVO) to Sell after mixed second quarter earnings has refocused attention on the stock, with investors weighing prescr...

Novo Nordisk Could Be 54% Undervalued Following Deutsche Bank Downgrade
The Wall Street Journal 3d
Novo Nordisk Shares Drop as Bank Downgrade Reflects Growth Concerns

Novo Nordisk announced that an application to sell its Wegovy weight-loss pill was accepted by Chinese regulators. Tom Little / Reuters Novo Nordisk NOVO.B -3....

Novo Nordisk Shares Drop as Bank Downgrade Reflects Growth Concerns
The Wall Street Journal 3d
Health Care Roundup: Market Talk

Yves Herman / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....

Health Care Roundup: Market Talk
TipRanks 3d
Novo Nordisk says China’s NMPA accepted application for marketing of Wegovy

The official website of the Center for Drug Evaluation of China’s National Medical Products Administration, NMPA, shows that Novo Nordisk’s (NVO) application fo...

TipRanks 3d
Novo Nordisk downgraded to Sell from Hold at Deutsche Bank

Deutsche Bank downgraded Novo Nordisk (NVO) to Sell from Hold with a price target of DKK 265, down from DKK 290. The firm says ziltivekimab is “now effectively...

MarketWatch 3d
Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak

While Ozempic maker Novo Nordisk has fallen on tough times, Wall Street analysts have still been reluctant to advise investors to sell the stock, until Deutsche...

Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak
Nasdaq 4d
NVO vs. GPCR: Which Obesity Stock Is the Better Buy Right Now?

Novo Nordisk NVO and Structure Therapeutics GPCR have emerged as noteworthy companies in the obesity space. A market leader in the GLP-1 space, Novo Nordisk ma...

NVO vs. GPCR: Which Obesity Stock Is the Better Buy Right Now?

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.